Showing results (151-160 of 166) with videos related to
Sort By:
Pageof 17
Nature Communications|April 11, 2024
Enhancing NSCLC recurrence prediction with PET/CT habitat imaging, ctDNA, and integrative radiogenomics-blood insightsSheeba J Sujit, Muhammad Aminu, Tatiana V Karpinets, et al.Cancer Discovery|June 13, 2015
Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilitiesFerdinandos Skoulidis, Lauren A Byers, Lixia Diao, et al.Nature Communications|May 12, 2021
Immune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular featuresHitoshi Dejima, Xin Hu, Runzhe Chen, et al.Cell Reports. Medicine|March 12, 2024
Synthetic PET from CT improves diagnosis and prognosis for lung cancer: Proof of conceptMorteza Salehjahromi, Tatiana V Karpinets, Sheeba J Sujit, et al.Science Translational Medicine|January 24, 2020
PI4KIIIβ is a therapeutic target in chromosome 1q-amplified lung adenocarcinomaXiaochao Tan, Priyam Banerjee, Edward A Pham, et al.Nature Communications|October 22, 2016
Genomic heterogeneity of multiple synchronous lung cancerYu Liu, Jianjun Zhang, Lin Li, et al.Nature Communications|April 5, 2022
MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancersOmar Alhalabi, Jianfeng Chen, Yuxue Zhang, et al.Cancer Discovery|May 11, 2021
Resolving the Spatial and Cellular Architecture of Lung Adenocarcinoma by Multiregion Single-Cell SequencingAnsam Sinjab, Guangchun Han, Warapen Treekitkarnmongkol, et al.Nature Communications|July 7, 2019
Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinomaXin Hu, Junya Fujimoto, Lisha Ying, et al.Journal of the National Cancer Institute|September 15, 2021
SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung AdenocarcinomasIchidai Tanaka, Delphine Dayde, Mei Chee Tai, et al.Pageof 17